The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Abbvie (I); Takeda (I)
Honoraria - Abbvie; Bristol-Myers Squibb; Merck Sharp & Dohme
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Consulting or Advisory Role - Abbott; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Speakers' Bureau - Abbott; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Progression after the next line of therapy (PFS2) and updated OS among patients (pts) with advanced NSCLC and PD-L1 tumor proportion score (TPS) ≥50% enrolled in KEYNOTE-024.
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck
 
Delvys Rodriguez-Abreu
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andrew George Robinson
Honoraria - Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Roche Canada (Inst)
 
Rina Hui
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Novartis; Pfizer
 
Tibor Csõszi
No Relationships to Disclose
 
Andrea Fülöp
Employment - DMC Hungary Private Hospital
 
Maya Gottfried
No Relationships to Disclose
 
Nir Peled
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Ali Tafreshi
Consulting or Advisory Role - Merck Sharp & Dohme
 
Sinead Cuffe
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
 
Mary O'Brien
No Relationships to Disclose
 
Suman Rao
Consulting or Advisory Role - AstraZeneca; Merck
Travel, Accommodations, Expenses - AstraZeneca; Merck
 
Katsuyuki Hotta
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical
 
Melanie A. Leiby
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jessica McLean
Employment - Merck
Travel, Accommodations, Expenses - Merck
 
Yue Shentu
Employment - Merck; Quest Diagnostics (I)
Stock and Other Ownership Interests - Merck
 
Reshma A. Rangwala
Employment - GlaxoSmithKline (I); Merck
Stock and Other Ownership Interests - Merck
 
Martin Reck
No Relationships to Disclose